Clinical Trial Update: Evaluation of Diabetes Care at Austrian GPs

View source ↗

Summary

AstraZeneca-sponsored trial evaluating diabetes care in Austrian general practitioners was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: TERMINATED